Coagulation and wound repair during COVID-19.
J Heart Lung Transplant
; 40(10): 1076-1081, 2021 10.
Article
in English
| MEDLINE | ID: covidwho-1267682
ABSTRACT
While COVID-19 is best known as a respiratory infection, SARS-CoV-2 causes systemic disease manifestations including coagulopathies. Both dysregulated extracellular matrix remodeling pathways and circulating coagulation proteins are hallmarks of severe COVID-19 and often continue after the resolution of acute infection. Coagulation proteins have proven effective as biomarkers for severe disease and anticoagulants are a mainstay of COVID-19 therapeutics in hospitalized patients. While much knowledge has been gained about the role of clotting pathway activation in COVID-19, much remains to be elucidated in this complex network of signaling pathways.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Wound Healing
/
Blood Coagulation Disorders
/
COVID-19
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Heart Lung Transplant
Journal subject:
Cardiology
/
Transplantation
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS